Rhythm Pharmaceuticals In... (RYTM)
NASDAQ: RYTM
· Real-Time Price · USD
63.73
-1.46 (-2.24%)
At close: May 01, 2025, 2:58 PM
Rhythm Pharmaceuticals Revenue
Rhythm Pharmaceuticals reported an annual revenue of $130.13M, reflecting a 68.06% growth. For the quarter ending December 31, 2024, Rhythm Pharmaceuticals generated $41.83M in revenue.
Revenue (ttm)
$130.13M
Revenue Growth
68.06%
Price / Sales Ratio
26.24
Revenue / Employee
$459.81K
Employees
283
Market Cap
4.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 130.13M | +68.06% |
| Dec 31, 2023 | 77.43M | +227.56% |
| Dec 31, 2022 | 23.64M | +649.46% |
| Dec 31, 2021 | 3.15M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |